Zhejiang Chemvplus Biotech

Zhejiang Chemvplus Biotech is a China-based Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) specializing in high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company provides a comprehensive suite of services ranging from early-stage process chemistry and R&D to commercial-scale manufacturing. Chemvplus distinguishes itself through the application of advanced technologies, including continuous flow chemistry, biocatalysis, and complex chiral synthesis. Their facilities are designed to meet international quality standards, supporting global pharmaceutical and biotech clients in accelerating drug development timelines. The company's core expertise lies in small molecule therapeutics across various therapeutic areas such as oncology and antiviral research.